Search
for
Sort by
Research 31–60 of 1000+
- A medicinal and edible formula YH0618 ameliorates the toxicity induced by Doxorubicin via regulating the expression of Bax/Bcl-2 and FOXO4
- Biomedical Applications of Bee Venom: A Natural Approach to Cancer, Infections, and Inflammatory Diseases
- Impact of Chemotherapeutic Drug on People living with Cancer
- Microneedles-A new paradigm in transdermal delivery of therapeutic agents
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Review of Hair Follicle Dermal Papilla cells as <i>in vitro</i> screening model for hair growth
- Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
- DRUG‐ASSOCIATED ALOPECIA
- Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
- Enhancing hair regeneration: Recent progress in tailoring nano-structured lipid carriers through surface modification strategies
- Economic Burden and Healthcare Resource Use of Alopecia Areata in an Insured Population in the USA
- Bioguided Fraction and Isolation of the Antitumor Components from<i>Phyllanthus niruri</i>L.
- Recent Advances in the Structural Design of Photosensitive Agent Formulations Using “Soft” Colloidal Nanocarriers
- Molecular Mechanisms of Vitexin: An Update on Its Anti-Cancer Functions
- Synthesis and biological activity evaluation of new isatin-gallate hybrids as antioxidant and anticancer agents (in vitro) and in silico study as anticancer agents and coronavirus inhibitors
- Recent Developments in Luteolin-Loaded Nanoformulations for Enhanced Anti-Carcinogenic Activities: Insights from In Vitro and In Vivo Studies
- Inhibitory effect of M50054, a novel inhibitor of apoptosis, on anti-Fas-antibody-induced hepatitis and chemotherapy-induced alopecia
- Cytotoxicity of bendamustine, alone and in combination with novel agents, toward adult T-cell leukemia cells
- A review on traditional uses, phytochemistry and pharmacology of Eclipta prostrata (L.) L.
- Repurposing of approved cardiovascular drugs
- THE GLOBAL CHALLENGE OF CHEMOTHERAPY TOXICITY: RETHINKING SUPPORTIVE CARE IN MODERN ONCOLOGY
- Topical delivery of nanoemulsions for skin cancer treatment
- Wound healing protects against chemotherapy-induced alopecia in young rats via up-regulating interleukin-1β-mediated signaling
- An In Situ Chemotherapy Drug Combined with Immune Checkpoint Inhibitor for Chemoimmunotherapy
- Probiotics in Dermatology: An Evidence-based Approach
- Pharmacotherapy for Keloids and Hypertrophic Scars
- Microneedle-Mediated Transdermal Drug Delivery for the Treatment of Multiple Skin Diseases
- When bugs and drugs conspire: driving acneiform skin toxicity
- High incidence of severe hand–foot syndrome during capecitabine–docetaxel combination chemotherapy